NANOCO GROUP PLC
("Nanoco", the "Group", or the "Company")
Director/PDMR Shareholding
The following replaces the RNS 'Director/PDMR Shareholding' announcement released on 2 May 2019 at 18:09 with RNS number 9561X.
The previous statement omitted the charitable transfer of an additional 60,000 shares by Dr Edelman and the reason for the share sale by Dr Edelman. All other information remains unchanged. The correct version of the announcement is below:
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, has been notified that Dr Michael Edelman, Chief Executive Officer, and Dr Nigel Pickett, Chief Technology Director, sold ordinary shares of 10p each in the Company as set out below. Dr Edelman's sale was carried out in order to repay a personal loan. In addition, Dr Edelman also transferred 60,000 Ordinary Shares into a charitable donor advised fund and ceases to have any economic interest in those shares.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification of Dealing Form
1. |
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA") |
|||||||
a) |
Name |
MICHAEL EDELMAN |
||||||
2. |
Reason for the notification: SALE OF ORDINARY SHARES |
|||||||
a) |
Position /status |
CHIEF EXECUTIVE OFFICER |
||||||
b) |
Initial notification / amendment |
INITIAL NOTIFICATION |
||||||
3. |
Details of the Issuer |
|||||||
a) |
Name |
NANOCO GROUP PLC |
||||||
b) |
LEI code |
213800HOSJEZO1KOCV33 |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Type of instrument: |
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES") |
||||||
ISIN: GB00B01JLR99 |
||||||||
b) |
Nature of the transaction |
SALE OF ORDINARY SHARES |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information: |
|
||||||
e) |
Date of the transaction |
30 APRIL 2019 TO 02 MAY 2019 |
||||||
f) |
Place of the transaction |
LONDON STOCK EXCHANGE |
1. |
Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA") |
|||||
a) |
Name |
NIGEL PICKETT |
||||
2. |
Reason for the notification: SALE OF ORDINARY SHARES |
|||||
a) |
Position /status |
CHIEF TECHNOLOGY OFFICER |
||||
b) |
Initial notification / amendment |
INITIAL NOTIFICATION |
||||
3. |
Details of the Issuer |
|||||
a) |
Name |
NANOCO GROUP PLC |
||||
b) |
LEI code |
213800HOSJEZO1KOCV33 |
||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Type of instrument: |
ORDINARY SHARES OF 1O PENCE EACH ("ORDINARY SHARES") |
||||
ISIN: GB00B01JLR99 |
||||||
b) |
Nature of the transaction |
SALE OF ORDINARY SHARES |
||||
c) |
Price(s) and volume(s) |
|
||||
d) |
Aggregated information: |
|
||||
e) |
Date of the transaction |
30 APRIL 2019 TO 02 MAY 2019 |
||||
f) |
Place of the transaction |
LONDON STOCK EXCHANGE |
This announcement contains inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014.
For further information, please contact:
Nanoco Group PLC:
Michael Edelman, CEO +44 (0) 161 603 7900
Brian Tenner, COO & CFO +44 (0) 161 603 7900
Caroline Watson, Investor Relations Manager +44 (0) 7799 897 357
cwatson@nanocotechnologies.com
MHP Communications: +44 (0) 203 128 8570
Reg Hoare
Giles Robinson
Pete Lambie
nanoco@mhpc.com